Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer

[1]  Peter Donnelly,et al.  A comparison of bayesian methods for haplotype reconstruction from population genotype data. , 2003, American journal of human genetics.

[2]  Henry J. Lin,et al.  Prostaglandin H synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[3]  S. Humphries,et al.  Common Promoter Variant in Cyclooxygenase-2 Represses Gene Expression: Evidence of Role in Acute-Phase Inflammatory Response , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[4]  P. Vineis,et al.  Metabolic gene polymorphism frequencies in control populations. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[5]  D. Bell,et al.  Functional characterization of cyclooxygenase-2 polymorphisms. , 2001, The Journal of pharmacology and experimental therapeutics.

[6]  Rajnish A. Gupta,et al.  Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 , 2001, Nature Reviews Cancer.

[7]  David G. Cox,et al.  Genotype transposer: automated genotype manipulation for linkage disequilibrium analysis , 2001, Bioinform..

[8]  D. Cox,et al.  Data mining: Efficiency of using sequence databases for polymorphism discovery , 2001, Human mutation.

[9]  N. Shen,et al.  Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis , 1999, Nature Genetics.

[10]  S. Hanauer,et al.  Hazard rates for dysplasia and cancer in ulcerative colitis , 1989, Digestive Diseases and Sciences.

[11]  J. Lennard-jones,et al.  Cancer in colitis: assessment of the individual risk by clinical and histological criteria. , 1977, Gastroenterology.

[12]  J. Rhodes,et al.  Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. , 2002, Trends in molecular medicine.